BNP Paribas Asset Management
HPTX

BNP Paribas Asset Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

BNP Paribas Asset Management’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-58,035
Closed -$1.5M – 979
2014
Q1 		$1.5M Buy
+58,035
New +$1.57M 0.01% 703

Other funds holding HPTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
HMPV
Highland Management Partners VII Cambridge, Massachusetts $5.57M AUM 94.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BNP Paribas Asset Management's HPTX Position: Q2 2014 in Review

BNP Paribas Asset Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2014, closing a stake of 58,035 shares — an estimated $1.5M sold.

BNP Paribas Asset Management first reported a position in HPTX in Q1 2014 and held it in 1 quarter. The position peaked at $1.5M in Q1 2014. 90 funds tracked by Wall St. Rank hold HPTX as of Q2 2014.

  • BNP Paribas Asset Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • BNP Paribas Asset Management sold 58,035 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2014, an estimated $1.5M.
  • BNP Paribas Asset Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q1 2014 and held it in 1 quarter.
  • BNP Paribas Asset Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $1.5M in Q1 2014.
  • 90 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2014.

Based on BNP Paribas Asset Management's 13F filing for Q2 2014, filed 13 Aug 2014.